Full metadata record

DC Field Value Language
dc.contributor.authorMin Cheol Chae-
dc.contributor.authorChang Kwon Park-
dc.contributor.authorDong Yoon Keum-
dc.contributor.authorIlseon Hwang-
dc.contributor.authorKun Young Kwon-
dc.contributor.authorByeong Churl Jang-
dc.date.accessioned2018-08-08T16:55:46Z-
dc.date.available2018-08-08T16:55:46Z-
dc.date.issued2014-
dc.identifier.citationKorean Journal of Thoracic and Cardiovascular Surgery, Vol.47(3) : 262-268, 2014-
dc.identifier.issn2233-601X-
dc.identifier.otheroak-aaa-4767-
dc.identifier.urihttp://kumel.medlib.dsmc.or.kr/handle/2015.oak/34627-
dc.description.abstractBackground The development of diagnostic techniques and an awareness of health examinations can bring about an early diagnosis of lung cancer. However, appropriate postoperative management and adjuvant chemotherapy remain under debate in postoperative therapeutic strategy. The present study was conducted to assess the clinicopathologic factors that influence recurrence and prognosis after complete resection of lung cancer. Methods The present study analyzed 62 patients with lung cancer who underwent complete resection of diagnosed adenocarcinoma between 1994 and 2007. In addition to conventional factors, which include staging factor and histological evaluation, the present study also performed univariate and multivariate analyses to consider claudin, a cell adhesion molecule, as a prognostic factor by immunohistochemical staining. Results There was no correlation between conventional factors, including lymphatic and vascular invasion, and recurrence. However, there was a significant correlation between high expression of claudin 4 and cancer recurrence. In particular, there was a correlation between high expressions of claudin 1, 4, and 5 and a reduction of disease-free survival. Conclusion Increased expressions of claudin 4 were negative prognostic factors in adenocarcinoma of the lung and thus could be used to identify high-risk patients for adjuvant chemotherapy, even if they had early-stage lung cancer. The present findings collectively suggest that consideration of claudin as a prognostic factor in the active postoperative treatment in patients at high risk will lead to better therapeutic outcomes with fewer side effects. Keywords: 1. Lung neoplasms, 2. Adenocarcinoma, 3. Discard, 4. Lung pathology, 5. Claudin-
dc.description.statementofresponsibilityopen-
dc.publisherSchool of Medicine-
dc.rightsBY_NC_ND-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.0/kr-
dc.subjectLung neoplasms-
dc.subjectAdenocarcinoma-
dc.subjectDiscard-
dc.subjectLung pathology-
dc.subjectClaudin-
dc.titlePrognostic Significance of Claudin 4 in Completely Resected Adenocarcinoma of the Lung-
dc.typeArticle-
dc.contributor.localauthor박창권-
dc.contributor.localauthor금동윤-
dc.contributor.localauthor장병철-
dc.contributor.localauthor황일선-
dc.contributor.localauthor권건영-
dc.contributor.alternativelocalauthorPark, Chang Kwon-
dc.contributor.alternativelocalauthorKeum, Dong Yoon-
dc.contributor.alternativelocalauthorJang, Byeong Churl-
dc.contributor.alternativelocalauthorHwang, Il Seon-
dc.contributor.alternativelocalauthorKwon, Kun Young-
dc.contributor.departmentDept. of Thoracic & Cardiovascular Surgery (흉부외과학)-
dc.contributor.departmentDept. of Molecular Medicine (분자의학)-
dc.contributor.departmentDept. of Pathology (병리학)-
dc.citation.volume47-
dc.citation.number3-
dc.citation.startpage262-
dc.citation.titleKorean Journal of Thoracic and Cardiovascular Surgery-
dc.citation.endpage268-
dc.identifier.doi10.5090/kjtcs.2014.47.3.262-


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE